Castle Biosciences director exercises 13,667 RSUs
Castle Biosciences director Kim Caple exercised equity awards into common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Castle Biosciences director Kim Caple exercised equity awards into common stock. On May 22, 2026, Caple converted 13,667 Restricted Stock Units into 13,667 shares of Common Stock at a price of $0.00 per share, classified as a derivative exercise rather than a market purchase.
Following this transaction, Caple directly holds 36,121 shares of Common Stock. The filing shows no open-market sales or gifts, indicating a routine compensation-related equity settlement rather than a discretionary trade. Each RSU represented the right to receive one share of Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 13,667 | $0.00 | $0.00 |
| Exercise | Common Stock | 13,667 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- F2. The RSUs vest in full on the earlier of the (a) one-year anniversary of the date on May 22, 2026, or (b) the day immediately preceding the next Annual Meeting of Stockholders following the date of the grant.
Key Figures
Key Terms
Restricted Stock Units financial
derivative security financial
Annual Meeting of Stockholders financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kim Caple report for CASTLE BIOSCIENCES (CSTL)?
Kim Caple reported exercising 13,667 Restricted Stock Units into 13,667 shares of Common Stock. This was a derivative exercise at $0.00 per share, reflecting settlement of equity compensation rather than an open-market stock purchase or sale.
How are Kim Caple’s Restricted Stock Units in CASTLE BIOSCIENCES structured?
Each Restricted Stock Unit represents the right to receive one share of CASTLE BIOSCIENCES Common Stock. The filing notes RSUs vest in full based on a time-based schedule linked to the one-year anniversary of May 22, 2026 or the next Annual Meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.